Recents Post
Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome
Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes through…
Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia.SHANGHAI, Sept. 7, 2026 /PRNewswire/ — On September 7, 2026, Shanghai, Cell…
Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
— Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection —- Robust neutralizing antibody responses across…
Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion
SHANGHAI, Sept. 6, 2026 /PRNewswire/ — Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up…
Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women
The association’s Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with clarity, confidence, and authenticity without sacrificing themselves in the processBOSTON, Aug. 29, 2026 /PRNewswire/ — The…
Global pharmacy leaders identify priorities for integrating pharmacists into primary health care
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ — Pharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on advancing pharmacists’ integration into primary health care, where they identified workforce readiness, sustainable funding models, supportive…
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate AHB-171 and next-generation combination approaches designed to advance functional cure for chronic hepatitis BSeries C brings AusperBio’s total…
Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health
SARALAND, Ala., Aug. 26, 2026 /PRNewswire/ — As students return to school, parents are busy with supply lists, shopping for clothes, and getting ready for a great year. One of the best ways to help children succeed is…
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
– ASP2138’s advancement into Phase 3 marks an important milestone in Astellas’ commitment to advancing research in CLDN18.2 with its differentiated portfolio, spanning approved treatments and investigational assets – TOKYO, Aug. 24, 2026 /PRNewswire/ — Astellas Pharma Inc. (TSE:…
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 23, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company, today announced that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduate…
